Labeler · US market

TARO PHARMACEUTICALS U.S.A., INC.

TARO PHARMACEUTICALS U.S.A., INC. is a US drug labeler with US FDA registrations covering 1 drug concept (1 currently active) across 2 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes51672

Active drugs1

Registrations1 active / 1

Packages2

Sole supplier of0 drugs

Portfolio1 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Zinc Oxide spray	otc	1	2	SUPPLYING

At a glance

TypeLabeler
Labeler codes51672
Filing names1
Drugs (active)1
Drugs (all time)1
US registrations1
Packages2

Recent events

Shortages, recalls, and registration changes across all filing names.

Aug 7, 2024
RECALLRecall (Class III): Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, …
Feb 25, 2022
RECALLRecall (Class III): Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceutic…
Dec 15, 2021
RECALLRecall (Class I): Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay,…
Jan 8, 2021
RECALLRecall (Class II): Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel …
Nov 17, 2020
RECALLRecall (Class II): CVS Health Athlete's Foot Cream, Clotrimazole Cream USP, 1%, Antifungal, NET WT 1 OZ (28.4 g) Distributed by: CVS Pharm…
Nov 17, 2020
RECALLRecall (Class II): Kroger Jock Itch Cream, Clotrimazole Cream USP, 1%, Antifungal Cream, NET WT .5 OZ (15 g), Distributed by The Kroger CO…
Nov 17, 2020
RECALLRecall (Class II): H-E-B - Athlete's Foot Cream Clotrimazole Cream USP, 1% Anitfungal NET WT. 0.5 oz. (14.2 g), Made with Pride & Care fo…
Nov 17, 2020
RECALLRecall (Class II): TopCare Health, Athlete's Foot Cream, Clotrimazole Cream USP, 1%, Antifungal, NET WT. 0.5 oz. (14.2 g). Distributed by …

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.